News Quantified

HSDT – helius medical technologies, inc. - class a (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. (NASDAQ: HSDT) had its "hold" rating re-affirmed by analysts at Maxim Group.

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece [Financial Post (Toronto, Ontario, Canada)]

0.7%

BEAT

Form 8-K HELIUS MEDICAL TECHNOLOG For: Nov 18

Form 10-Q HELIUS MEDICAL TECHNOLOG For: Sep 30

Form SC 13G/A HELIUS MEDICAL TECHNOLOG Filed by: Hudson Bay Capital Management LP

Top News Gainers

12/19 Independent Research Published Show Positive Results on Translingual Neurostimulation Plus Physical Therapy With Statistically Significant Improvement in Balance and Gait Scores and the Outcomes Were Sustained for 12 Weeks After Discontinuing Treatment 55.8%

4/28 Form PRE 14A HELIUS MEDICAL TECHNOLOG For: Jun 10 27.4%

4/16 Form 8-K HELIUS MEDICAL TECHNOLOG For: Apr 13 19.4%

1/16 Helius Medical Technologies, Inc. and University Health Network (UHN) Have Signed an Agreement for UHN and three Neuro-Rehabilitation Centers to Perform a Clinical Experience Program of the PoNS™ Device in Canada 17.8%

1/15 Helius Medical Technologies Inc (OTCMKTS: HSDT) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 13.7%

5/1 Form 4 HELIUS MEDICAL TECHNOLOG For: Apr 30 Filed by: Deschamps Philippe 10.2%

4/30 Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI 7.2%

11/25 Form 424B5 HELIUS MEDICAL TECHNOLOG 6.9%

6/5 Helius Medical Technologies, Inc. Announces Addition of Three New PoNS™ Authorized Clinics in Canada 6.4%

1/3 Form 4 HELIUS MEDICAL TECHNOLOG For: Dec 31 Filed by: Deschamps Philippe 6.1%

Top News Decliners

3/18 Helius Medical Technologies Announces $2.2 Million Registered Direct Offering -34.2%

11/21 Helius Medical Technologies, Inc. Announces Proposed Public Offering -32.8%

11/12 Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook -15.8%

3/24 Form 8-K HELIUS MEDICAL TECHNOLOG For: Mar 24 -11.4%

1/16 Helius Medical Technologies, Inc. Issues a Clarification to the News Release Regarding the Agreement with the University Health Network (UHN) Issued at 7:05 am January 16, 2020 -11.1%

5/9 Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook -10.2%

3/9 Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment™ Clinics -9.8%

1/27 Form 8-K HELIUS MEDICAL TECHNOLOG For: Jan 27 -8.7%

4/30 Form 8-K HELIUS MEDICAL TECHNOLOG For: Apr 30 -6.8%

3/2 Form 8-K HELIUS MEDICAL TECHNOLOG For: Mar 02 -6.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day